BioSpace News Archive

Drug Development

Amgen Puts Pressure on Mirati with Phase III Lung Cancer Win

Amgen announced Tuesday that initial Phase III data of Lumakras in KRAS G12C-mutated NSCLC met the primary endpoint of progression-free survival.

August 31, 2022
·
3 min read
·
Tristan Manalac
Policy

Universities of Michigan and South Florida Sue Novartis Over Entresto Patents; Lawsuit Updates

The University of Michigan and the University of South Florida have filed a lawsuit against Novartis, alleging the company’s cardiac drug, Entresto, infringes a cocrystal patent held by both universities.

August 31, 2022
·
2 min read
·
Mark Terry
Genetown

Report: $5B+ in VC Funding Fuels Massachusetts Life Sciences Engine

A 2022 Industry Snapshot from MassBio shows there continues to be significant growth across the Massachusetts ecosystem, driven by billions of dollars in venture capital investments.

August 31, 2022
·
3 min read
·
Alex Keown
Policy

US, Australia Make Heavy Investments in Pandemic Preparedness Research

In the wake of the COVID-19 pandemic, several Western nations are investing heavily in rapidly developing drugs to treat populations when new pandemics emerge.

August 31, 2022
·
2 min read
·
Mark Terry
Drug Development

Wuhan Lab Possibly Linked to COVID-19 Discovers Novel Animal Virus

Researchers at the Wuhan Institute of Virology (WIV), which is potentially linked to the origins of COVID-19, reported the discovery of a novel DNA virus in animals in the journal Virologica Sinica.

August 31, 2022
·
3 min read
·
Mark Terry
CCDC Announces New Engagement Grants to Inspire the Next Generation of Scientists

New Initiative to create resources to increase engagement in crystallography and structural science

August 31, 2022
·
2 min read
Business

Money on the Move: Mesoblast, Iantrek, Jenavalve and More

Mesoblast fell short of analyst forecasts this week, and money is pouring into glaucoma, medical devices for heart disease and chronic endocrine conditions.

August 31, 2022
·
4 min read
·
Tristan Manalac
FDA

FDA Opioid Review Slow to Produce Actionable Results

The long-awaited review of problematic opioid prescribing is taking longer than observers had hoped.

August 31, 2022
·
1 min read
·
Alex Keown
Career Advice

6 Life Science Jobs that Don’t Require Industry Experience

The life science field offers a wealth of opportunities, even for those working outside of the field. Here are six life science jobs that don’t require industry experience.

August 31, 2022
·
4 min read
·
Franklin Carpenter
Drug Development

100 Dedicated Employees Answer the Clarion Call for Kids’ Cancer Drugs

Day One Biopharmaceuticals aims to provide a business solution to a moral problem: the inequity in pediatric oncology drug development.

August 31, 2022
·
7 min read
·
Heather McKenzie